Parvinder Thiara

Parvinder Thiara is a declared insider at 2 companies; the most frequent names are Talaris Therapeutics, Inc. and Zura Bio Ltd. Over a trading history stretching from 19 October 2023 to 28 October 2025, the count stands at 8 filings.

In open-market terms, that means 3 purchases worth €89k on one side and 3 sales worth €19.4M on the other. The net balance comes to €19.3M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant.

In size, the median ticket on the buying side is €23k. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 28 October 2025, the filings show a transaction in Talaris Therapeutics, Inc. The most recent open-market purchase was published on 20 November 2023, 1,086 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.